neurocoach.
My Care Plan
Explore optionsBrain stimulation

BRAIN STIMULATION

Theta-burst TMS (iTBS/cTBS): depression and OCD research

Patterned TMS: established depression uses and a separate, emerging OCD evidence base. The exact protocol matters.

NeuroCoach · Evidence explorerSources checked 2026-10-08Editorial draft · clinical review pending

How it works

Intermittent theta-burst stimulation delivers pulses in short bursts, so a session can take about 3 minutes instead of ~37. Accelerated protocols give several sessions per day; SAINT adds MRI-guided targeting and 10 sessions a day for 5 days.

What the evidence says, use by use

Evidence is specific to the condition, population and—for devices—the exact product. One label never covers everything.

OCD: OCD symptoms with theta-burst protocols

Emerging / limited
Who was studied / who it’s for: Adults with OCD in small studiesRegulatory status: Depression clearance does not establish clearance for OCD. Ask for the exact device and OCD protocol indication; a proposed use may be off-label or research.What this label means: Early, small or mixed studies. Interesting, but not equivalent to established care.

Results are mixed: a 27-person sham-controlled trial published in 2026 was inconclusive, while a 2025 accelerated deep-iTBS study found a signal with important statistical limitations. Protocols and targets differ; these results do not establish a routine replacement for ERP or an OCD-cleared TMS protocol.

Sources: Rymaszewska et al., Journal of Affective Disorders (2026) · Randomized controlled study (2025)

Depression: Treatment-resistant depression (standard iTBS)

Established
Who was studied / who it’s for: AdultsRegulatory status: FDA-cleared iTBS systems for major depressive disorder.What this label means: Strong research and/or authoritative clinical guidelines support this specific use.

In the large THREE-D trial, 3-minute iTBS was non-inferior to standard 37-minute rTMS; FDA cleared iTBS for depression in 2018.

Sources: Frontiers in Human Neuroscience (2018), commentary on the THREE-D trial (Lancet 2018)

Depression: Treatment-resistant depression (accelerated SAINT protocol)

Promising
Who was studied / who it’s for: Adults who haven’t improved with antidepressantsRegulatory status: FDA-cleared (2022) SAINT neuromodulation system.What this label means: Meaningful evidence exists for this use, but important questions remain—about size of benefit, who benefits, or long-term effects.

FDA cleared the SAINT system in 2022 after a randomized trial with high remission rates; larger and longer-term studies and real-world access are still developing.

Sources: Brain & Behavior Research Foundation (2022)

Who usually provides it

TMS clinics and academic centers.

Cautions & things to know

  • Accelerated protocols are newer, availability is limited and insurance coverage varies.
  • 'Accelerated' clinic protocols are not all the same as the cleared SAINT protocol.

Questions for a clinician

Conversation prompts, not a treatment plan.

  • Which exact device, target and protocol do you propose for OCD or depression, and what is its clearance for that use?
  • How do you choose the target—scalp measurements or MRI?

Educational, not medical advice. NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Sources

Sources checked 2026-10-08. Educational editorial draft; clinical review pending.

  1. Theta-burst add-on randomized trial in treatment-resistant OCD Rymaszewska et al., Journal of Affective Disorders (2026)
  2. Accelerated deep intermittent theta-burst stimulation for OCD Randomized controlled study (2025)
  3. Theta burst vs. high-frequency rTMS for depression: a randomized non-inferiority trial Frontiers in Human Neuroscience (2018), commentary on the THREE-D trial (Lancet 2018)
  4. FDA clears SAINT rapid-acting brain stimulation approach for treatment-resistant major depression Brain & Behavior Research Foundation (2022)